Care Property Invest NV (CPINV)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 12.20 |
|---|---|
| 52-week range | 10.70 – 14.04 |
| Return, 1 month / 3 months | −2.1% / −3.8% |
| Return, 1 year / 3 years | +15.4% / +40.7% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 19.4% |
| Worst drawdown (1 year) | -14.9% |
| Average daily value traded | 0.55M EUR |
| Dividend yield | 8.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Care Property Invest NV is a Belgian property company that invests in real estate for healthcare and senior living. It owns and leases residential care centres, assisted living complexes and other facilities for elderly and disabled people, working with care operators as its tenants. The company is based in Belgium and also holds properties in neighbouring countries. Its income comes from long-term rental agreements with the organisations that run the care services in its buildings.
On this site Care Property Invest NV appears as a stock on the Euronext Brussels (Belgium), code CPINV, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Care Property Invest NV (CPINV) trades on the Euronext Brussels in Belgium. It last closed at EUR 12.20 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 22 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.4% and over the last three months it fell 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.4% | ||
| From 52-week high | -12.4% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.8% | ||
| 6-month return | -4.1% | ||
| 12-month return, skipping the last month | 17.9% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.9% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.55M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 93 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | −2.1% |
| 3 months | −3.8% |
| 6 months | −4.1% |
| 1 year | +15.4% |
| 3 years | +40.7% |
| 5 years | −32.0% |
Signals
| 50-day / 200-day average | 12.23 / 12.50 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | EUR 0.0767 |
| 4 Dec 2025 | EUR 0.9233 |
| 30 May 2025 | EUR 1.0000 |
| 31 May 2024 | EUR 1.0000 |
| 11 Jan 2023 | EUR 1.0000 |
| 27 May 2022 | EUR 0.1239 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.